- 1.2 Health workforce1.6 Vaccine safety2.1 Political and financial commitment2.2 Demand for immunization3.2 High & equitable coverage4.1 Life-course vaccination5.1 Outbreak detection and response6.1 Healthy global markets for vaccines6.2 Financial resources for imm. programmes6.3 Imm. expenditure from domestic resources7.1 Capacity for innovation
Type to select a Country
Impact Goal 2: Promote Equity
2.2
Provide access to all vaccines
What Does this Indicator Measure?
Introduction of new or underutilized vaccines in low- and middle-income countries.
How Will Progress be Measured?
The target is 500 vaccine introductions in low- and middle-income countries by 2030, including current new or under-utilized vaccine introductions (NUVI) as well as vaccines that will be recommended over the decade. Progress will be evaluated annually.
Introduction of new or underutilized vaccines in low- and middle-income countries—Global
200
180
160
140
120
100
80
60
40
20
0
28
2020
167
2021
2030 Target
Average of 50 annual introductions
Target: At least
500
cumulative vaccine introductions in low- and middle-income countries by 2030
On track towards 2030 target
Summary Table
| Vaccine introductions | 2020 | 2021 |
|---|---|---|
| Total | 28 | 167 |
| Covid | 4 | 127 |
| DTP Booster | 0 | 2 |
| HepB BD | 1 | 0 |
| HiB | 0 | 0 |
| HPV | 4 | 5 |
| IPV2 | 4 | 17 |
| PCV | 2 | 5 |
| Rotavirus | 4 | 4 |
| Rubella | 0 | 0 |
| Cholera | 0 | 0 |
| Hep A | 1 | 0 |
| Influenza | 5 | 3 |
| JE | 0 | 0 |
| MenA | 0 | 1 |
| Multivariant Men | 0 | 0 |
| Mumps | 1 | 0 |
| Rabies | 0 | 0 |
| Typhoid | 0 | 0 |
| Varicella | 0 | 0 |
| Yellow Fever | 0 | 0 |
| MCV2 | 2 | 3 |
Definition:
Introductions are defined as addition of a vaccine to the national immunization schedule and use of the vaccine for a sustained period of at least 12 months (excludes vaccines used only in the private sector that are not in national immunization schedule; includes vaccines in national immunization schedules that are used in at-risk populations, e.g., seasonal influenza).
New or underutilized vaccines are defined as vaccines that have not yet been introduced into national immunization schedules in all countries where recommended by WHO.
Measurement approach: Vaccines included in this indicator that are recommended by WHO for use in national immunization schedules in all countries: HepB birth dose, Hib, HPV, IPV2, MCV2, PCV, rotavirus, rubella, DTP booster (currently reporting the fourth dose at any age), and COVID-19 (interim recommendation). Vaccines included in this indicator that are recommended by WHO for use in national immunization schedules in countries in certain geographic region(s), in some high-risk populations, or in immunization programmes with certain characteristics: YF, JE, MenA, multivariate meningitis, typhoid, cholera, dengue, rabies, HepA, influenza, varicella, and mumps.
Calculation: Count of the number of country vaccine introductions for WHO recommended vaccines reported from 2021-2030.
Data source: WHO/UNICEF Joint Reporting Form on Immunization (JRF)
